Anixa Biosciences Inc
ANIX
Nasdaq
Manufacturing
Chemicals
2,70 €
▼
0,03 €
(-1,10%)
Cap. Boursière: 90,53 M
Prix
2,70 €
Cap. Boursière
90,53 M
Fourchette du Jour
2,62 € — 2,74 €
Fourchette 52 Semaines
2,44 € — 5,46 €
Volume
49 476
Ouverture 2,71 €
Moyenne 50J / 200J
2,86 €
5,69% below
Moyenne 50J / 200J
3,40 €
20,59% below
Historique des Prix
Tendances Financières
No fundamental snapshot available yet.
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | 210 000,0 | 210 000,0 | 512 500,0 | 250 000,0 |
| Net Income | -10,93 M | -12,55 M | -9,81 M | -13,60 M | -10,02 M |
| EPS (Diluted) | -0,34 | -0,39 | 0,32 | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -11,70 M | -13,83 M | -11,01 M | -13,88 M | -9,98 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 5,07 M | 6,40 M | 4,77 M | 6,70 M | 4,38 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 16,08 M | 21,59 M | 25,52 M | 30,41 M | 9,45 M |
| Total Liabilities | 2,13 M | 2,70 M | 2,15 M | 2,21 M | — |
| Shareholders' Equity | 15,16 M | 20,00 M | 24,34 M | 29,05 M | 8,76 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 1,24 M | 1,27 M | 915 000,0 | 12,36 M | 6,42 M |
| Current Assets | 15,89 M | 21,36 M | 25,36 M | 30,20 M | 9,37 M |
| Current Liabilities | 1,97 M | 2,50 M | 2,03 M | 2,04 M | 1,19 M |
{"event":"ticker_viewed","properties":{"ticker":"ANIX","listing_kind":"stock","pathname":"/stocks/anix","exchange":"Nasdaq","country":"US"}}